Print Mode Enable Media Only

News chronological

10 items since 1086386

NYTIMES (Farah Stockman) - American Factories Lag in Adopting A.I. This Drugmaker Is an Exception.

A Bristol Myers Squibb plant that makes cancer drugs was the only manufacturer in the U.S. recognized for innovation by the World Economic Forum this year.

NYTIMES (Lara Jakes and Andrada Lautaru) - In Romania, Living With Weapons of War Spilling Into NATO Territory

Four years of battle in Ukraine is taking a toll on neighboring Romanians. Even if the war has not crossed the border, drones have done so.

NYTIMES (Tariq Panja, Emma Bubola, Lucía Cholakian Herrera and Sarah Pabst) - World Cup Dynamic Ticket Pricing Drives Argentine Soccer Fans To Extremes

Dynamic ticket pricing has made this year’s tournament the most expensive in history, pushing Argentine fans to extremes.

NYTIMES (Danny Hakim) - A Look Inside the Case That Enshrined Political Power for Billionaires

After Watergate, Congress tried to curtail the role of money in politics. But a pivotal Supreme Court case nipped it in the bud. Years later, new details are emerging on how wealthy Americans were conferred with a “right to spend” on elections.

NYTIMES (Pam Belluck) - Tofersen, a New Treatment for A.L.S., Reverses Symptoms for Some

The drug is for a small subset of patients. But evidence that breathing and strength can get better for some of them is remarkable for a paralyzing, usually fatal disease.

WASHINGTONPOST (Susan Svrluga) - How college students are learning to socialize without cellphones

College leaders and students are organizing phone-free spaces to foster real-life connections and address the negative impacts of technology.

WASHINGTONPOST (Michelle Boorstein, Scott Clement) - Poll finds broad rejection of religion-related messages from Trump, Hegseth

Americans rate Pope Leo positively but are deeply critical of the president’s social media post that appeared to depict him as Jesus, the Post-ABC-Ipsos poll found.

NPR (Jackie Fortiér) - A new Medicare option for weight loss drugs is coming: Here's what to know

Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work.